Hinge Health Reports Second Quarter 2025 Financial Results

About this update from Hinge Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":283,"url":"https://media.zenfs.com/en/business-wire.com/aca2da5f4478f60dac770733b4308f48"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Q70KjzkYlnR9QJ1FMlqdBA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU2NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/aca2da5f4478f60dac770733b4308f48","width":480,"height":283}},"lazy":false},{"type":"text","content":"SAN FRANCISCO, August 05, 2025--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025.","length":158,"tagName":"p"},{"type":"text","content":""In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we’re excited about our momentum and are moving with haste to capture this opportunity."","length":392,"tagName":"p"},{"type":"text","content":"Second Quarter 2025 Financial Highlights:","length":41,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue increased 55% year-over-year to $139.1 million compared to revenue of $89.8 million in Q2 2024.","length":103,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP gross margin was 70% compared to 74% in Q2 2024. Non-GAAP gross margin was 83% compared to 77% in Q2 2024.","length":111,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP loss from operations was $580.7 million, which included $591.0 million in stock-based compensation expense, compared to GAAP loss from operations of $17.6 million in Q2 2024. Non-GAAP income from operations was $26.1 million compared to non-GAAP loss from operations of $14.4 million in Q2 2024.","length":300,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net cash provided by operating activities was $20.2 million compared to a net cash provided by operating activities of $14.9 million during Q2 2024. Free cash flow was $32.6 million, which included an adjustment of $14.2 million for employer taxes related to stock-based compensation at IPO, compared to free cash flow of $...

More updates from Hinge Health, Inc.